Skip to main content
Retour
Watch Compare

NATURAL HEALTH TRENDS CORP

Qualité des données : 100%
NHTC
Nasdaq Wholesale Trade Nondurable Goods Wholesale
2,87 €
▲ 0,02 € (0,70%)
Cap. Boursière: 24,45 M
Prix
2,85 €
Cap. Boursière
24,45 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -9,77% annually over 5 years
Earnings declined -254,20% over the past year
Negative free cash flow of -6,07 M
Capital efficient — spends only 0,17% of revenue on capex

Croissance

Revenue Growth (5Y)
-9,77%
En dessous de la moyenne du secteur (3,59%)
Revenue (1Y)-7,42%
Earnings (1Y)-254,20%
FCF Growth (3Y)N/A

Qualité

Return on Equity
-3,21%
Au-dessus de la moyenne du secteur (-3,22%)
ROIC-4,95%
Net Margin-2,22%
Op. Margin-4,55%

Sécurité

Debt / Equity
N/A
Current Ratio2,57
Interest CoverageN/A

Valorisation

PE (TTM)
-27,72
En dessous de la moyenne du secteur (-0,16)
P/B Ratio0,93
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Wholesale Trade (91 pairs)
Métrique Action Médiane du Secteur
P/E -27,7 -0,2
P/B 0,9 1,0
ROE % -3,2 -3,2
Net Margin % -2,2 -2,2
Rev Growth 5Y % -9,8 3,6
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

ETFs Holding This Stock

BRUSX BRUSX
0,08% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -7,42% Revenue Growth (3Y) -4,84%
Earnings Growth (1Y) -254,20% Earnings Growth (3Y) N/A
Revenue Growth (5Y) -9,77% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 39,78 M Net Income (TTM) -882 000,0
ROE -3,21% ROA -2,02%
Gross Margin 73,54% Operating Margin -4,55%
Net Margin -2,22% Free Cash Flow (TTM) -6,07 M
ROIC -4,95% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,57
Interest Coverage N/A Asset Turnover 0,91
Working Capital 23,13 M Tangible Book Value 26,15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -27,72 Forward P/E N/A
P/B Ratio 0,93 P/S Ratio 0,61
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24,81%
Market Cap 24,45 M Enterprise Value 10,11 M
Per Share
EPS (Diluted TTM) -0,08 Revenue / Share 4,64
FCF / Share -0,71 OCF / Share -0,70
EPS CAGR (1Y) -260,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,17% FCF Conversion 687,64%
SBC-Adj. FCF -6,20 M Growth Momentum 2,35

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 39,78 M 42,96 M 43,92 M 49,13 M 60,01 M
Net Income -882 000,0 572 000,0 568 000,0 313 000,0 1,09 M
EPS (Diluted) -0,08 0,05 0,05 0,03 0,09
Gross Profit 29,25 M 31,79 M 32,75 M 36,47 M 45,00 M
Operating Income -1,81 M -1,30 M -1,67 M -270 000,0 1,57 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 14,76 M 15,51 M 16,01 M 16,00 M 17,85 M
D&A 109 000,0 131 000,0 164 000,0 204 000,0 299 000,0
Interest Expense — — — — —
Income Tax 315 000,0 48 000,0 177 000,0 289 000,0 425 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 38,43 M 55,36 M 69,09 M 82,82 M 98,36 M
Total Liabilities 15,00 M 22,49 M 27,49 M 32,67 M 38,87 M
Shareholders' Equity 23,43 M 32,87 M 41,60 M 50,15 M 59,49 M
Total Debt — — — — —
Cash & Equivalents 6,81 M 13,53 M 56,18 M 69,67 M 83,84 M
Current Assets 34,19 M 50,98 M 64,23 M 77,55 M 93,47 M
Current Liabilities 13,69 M 20,80 M 19,98 M 20,44 M 24,66 M